Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial

Guy Young, MD, Peter W. Collins, MD, Ramin Tehranchi, MD, PhD, Ampaiwan Chuansumrit, Hideji Hanabusa, MD, Steven R. Lentz, MD PhD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Evelien Mauser-Bunschoten, Claude Negrier, Johannes Oldenburg, MD PhD, Turkan Patiroglu, MD, Elena Santagostino, MD PhD, Marek Zak, Fara Abdul Karim

Blood (2014) 124 (21): 2846.

https://doi.org/10.1182/blood.V124.21.2846.2846

Published: 2014

Journal Articles

Genetic Background in Patients with Severe Factor XIII A-Subunit Deficiency Treated with Recombinant FXIII

Vytautas Ivaskevicius, MD, Arijit Biswas, MD, Anne Thomas, MD, Ramin Tehranchi, M.D., Ph.D., Johannes Oldenburg, MD

Blood (2012) 120 (21): 1125.

https://doi.org/10.1182/blood.V120.21.1125.1125

Published: 2012

Journal Articles

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Aida Inbal, Johannes Oldenburg, Manuel Carcao, Anders Rosholm, Ramin Tehranchi, Diane Nugent

Blood (2012) 119 (22): 5111–5117.

https://doi.org/10.1182/blood-2011-10-386045

Published: 2012

Journal Articles

Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency

Aida Inbal, MD, Johannes Oldenburg, MD, Manuel Carcao, MD, BSC, Anders Rosholm, MSc, PhD, Ramin Tehranchi, MD, PhD, Diane J Nugent, MD

Blood (2010) 116 (21): 20.

https://doi.org/10.1182/blood.V116.21.20.20

Published: 2010

Journal Articles

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Lars Nilsson, MD, PhD, Patrik Edén, PhD, Eleonor Olsson, Robert Månsson, Ingbritt Åstrand-Grundström, Bodil Strömbeck, Ramin Tehranchi, MD, PhD, Kim Theilgaard-Mönch, Robert Hast, MD, PhD, Eva Hellström-Lindberg, MD, PhD, Jan Samuelsson, MD, PhD, Gösta Bergh, MD, PhD, Bertil Johansson, MD, PhD, Mikael Sigvardsson, PhD, Åke Borg, PhD, Sten-Eirik W. Jacobsen, MD, PhD

Blood (2005) 106 (11): 4382.

https://doi.org/10.1182/blood.V106.11.4382.4382

Published: 2005

Journal Articles

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

Ramin Tehranchi, Rosangela Invernizzi, Alf Grandien, Boris Zhivotovsky, Bengt Fadeel, Ann-Mari Forsblom, Erica Travaglino, Jan Samuelsson, Robert Hast, Lars Nilsson, Mario Cazzola, Rolf Wibom, Eva Hellström-Lindberg

Blood (2005) 106 (1): 247–253.

https://doi.org/10.1182/blood-2004-12-4649

Published: 2005

Journal Articles

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Ramin Tehranchi, MD, Rosangela Invernizzi, MD, PhD, Boris Zhivotovsky, PhD, Bengt Fadeel, MD, PhD, Ann-Mari Forsblom, Erica Travaglino, Jan Samuelsson, MD, Robert Hast, MD, PhD, Lars Nilsson, MD, PhD, Rolf Wibom, PhD, Alf Grandien, PhD, Mario Cazzola, MD, PhD, Eva Hellstrom-Lindberg, MD, PhD

Blood (2004) 104 (11): 473.

https://doi.org/10.1182/blood.V104.11.473.473

Published: 2004

Journal Articles

The WHO classification of MDS does make a difference

Robert B. Howe, Anna Porwit-MacDonald, Robert Wanat, Ramin Tehranchi, Eva Hellström-Lindberg

Blood (2004) 103 (9): 3265–3270.

https://doi.org/10.1182/blood-2003-06-2124

Published: 2004

Journal Articles

Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells

Göran Carlsson, Andrew A. G. Aprikyan, Ramin Tehranchi, David C. Dale, Anna Porwit, Eva Hellström-Lindberg, Jan Palmblad, Jan-Inge Henter, Bengt Fadeel

Blood (2004) 103 (9): 3355–3361.

https://doi.org/10.1182/blood-2003-04-1011

Published: 2004

Journal Articles

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

Ramin Tehranchi, Bengt Fadeel, Ann-Mari Forsblom, Birger Christensson, Jan Samuelsson, Boris Zhivotovsky, Eva Hellstrom-Lindberg

Blood (2003) 101 (3): 1080–1086.

https://doi.org/10.1182/blood-2002-06-1774

Published: 2003

NARROW

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial

Genetic Background in Patients with Severe Factor XIII A-Subunit Deficiency Treated with Recombinant FXIII

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

The WHO classification of MDS does make a difference

Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only